Modulation of Nrf2/ARE and inflammatory signaling pathways by Hericium erinaceus mycelia extract

Food Science and Biotechnology

Volumn 18, Issue 5, 2009, Pages 1204-1211

  Jin, Kyong Suk ^a   Park, Ji Young ^a   Cho, Mi Kyung ^a   Jang, Ji Hyun ^a   Jeong, Jae Han ^a   Ok, Seon ^a   Bak, Min Ji ^a   Song, Young Sun ^a   Kim, Myo Jeong ^a   Cho, Chung Won ^a   Jeong, Woo Sik ^a  

^a Inje University   (South Korea)

Author keywords

Antiinflammation; Antioxidant response element (ARE); Chemoprevention; Hericium erinaceus mycelia; Nuclear factor E2 related factor 2 (Nrf2)

Indexed keywords

ANTI-INFLAMMATION; ANTIOXIDANT RESPONSE ELEMENTS; CHEMOPREVENTION; HERICIUM ERINACEUS MYCELIA; NUCLEAR FACTORS;

GENES; NITRIC OXIDE; SIGNALING; TRANSCRIPTION; TRANSCRIPTION FACTORS; TUMORS;

SOLVENT EXTRACTION;

BASIDIOMYCOTA; ERINACEIDAE; ERINACEUS; HERICIUM ERINACEUM;

EID: 79954599447     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Yang BK, Park JB, Song CH. Hypolipidemic effect of an exobiopolymer produced from a submerged mycelial culture of Hericium erinaceus. Biosci. Biotech. Bioch. 67: 1292-1298 (2003)
2. Mizuno T, Wasa T, Ito H, Suzuki C, Ukai N. Antitumor-active polysaccharides isolated from the fruiting body of Hericium erinaceum, an edible and medicinal mushroom called yamabushitake or houtou. Biosci. Biotech. Bioch. 56: 347-348 (1992)
3. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbiol. Biot. 60: 258-274 (2002)
4. Borchers AT, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity: An update. Exp. Biol. Med. 229: 393-406 (2004)
5. Xu CP, Liu WW, Liu FX, Chen SS, Liao FQ, Xu Z, Jiang LG, Wang CA, Lu XH. A double-blind study of effectiveness of Hericium erinaceus pers therapy on chronic atrophic gastritis. A preliminary report. Chinese Med. J. Peking 98: 455-456 (1985)
6. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom yamabushitake (Hericium erinaceus) on mild cognitive impairment: A double-blind placebo-controlledclinical trial. Phytother. Res. 23: 367-372 (2008)
7. Park YS, Lee HS, Won MH, Lee JH, Lee SY, Lee HY. Effect of an exo-polysaccharide from the culture broth of Hericium erinaceus on enhancement of growth and differentiation of rat adrenal nerve cells. Cytotechnology 39: 155-162 (2002)
8. Mori K, Obara Y, Hirota M, Azumi Y, Kinugasa S, Inatomi S, Nakahata N. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol. Pharm. Bull. 31: 1727-1732 (2008)
9. Wang JC, Hu SH, Wang JT, Chen KS, Chia YC. Hypoglycemic effect of extract of Hericium erinaceus. J. Sci. Food Agr. 85: 64-646 (2004)
10. Jeong WS, Jun M, Kong AN. Nrf2: A potential molecular target for cancer chemoprevention by natural compounds. Antioxid. Redox. Sign. 8: 99-106 (2006)
11. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Bioph. Res. Co. 236: 313-322 (1997)
12. Kong AN, Yu R, Hebbar V, Chen C, Owuor E, Hu R, Ee R, Mandlekar S. Signal transduction events elicited by cancer prevention compounds. Mutat. Res. 480-481: 231-241 (2001)
13. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3: 768-780 (2003)
14. Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol. 76: 967-973 (2008)
15. Khor TO, Yu S, Kong AN. Dietary cancer chemopreventive agents - targeting inflammation and Nrf2 signaling pathway. Planta Med. 74: 1540-1547 (2008)
16. Gonzalez-Gallego J, Sanchez-Campos S, Tunon MJ. Antiinflammatory properties of dietary flavonoids. Nutr. Hosp. 22: 287-293 (2007)
17. Osburn WO, Kensler TW. Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults. Mutat. Res. 659: 31-39 (2008)
18. Kundu JK, Surh YJ. Inflammation: Gearing the journey to cancer. Mutat. Res. 659: 15-30 (2008)
19. Soh JW, Weinstein IB. Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. Prog. Exp. Tumor Res. 37: 261-285 (2003)
20. Oshima M, Taketo MM. COX selectivity and animal models for colon cancer. Curr. Pharm. Design 8: 1021-1034 (2002)
21. Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh H, Kim GY, Choi YH, Kim ND. A chenodeoxycholic derivative, hs-1200, induces apoptosis, and cell cycle modulation via egr-1 gene expression control on human hepatoma cells. Cancer Lett. 270: 77-86 (2008)
22. Bae SJ, Choi YH. Methanol extract of the seaweed Gloiopeltis furcata induces G2/M arrest and inhibits cyclooxygenase-2 activity in human hepatocarcinoma HepG2 cells. Phytother. Res. 21: 52-57 (2007)
23. Prabhu KS, Zamamiri-Davis F, Stewart JB, Thompson JT, Sordillo LM, Reddy CC. Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: Role of nuclear factor-kappaB in up-regulation. Biochem. J. 366: 203-209 (2002)
24. Luoma JS, Yla-Herttuala S. Expression of inducible nitric oxide synthase in macrophages and smooth muscle cells in various types of human atherosclerotic lesions. Virchows Arch. 434: 561-568 (1999)
25. Leiro JM, Alvarez E, Arranz JA, Cano E, Orallo F. Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/ COX-2 gene and protein expression in rat peritoneal macrophages. Int. Immunopharmacol. 4: 163-177 (2004)
26. Lo AH, Liang YC, Lin-Shiau SY, Ho CT, Lin JK. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages. Carcinogenesis 23: 983-991 (2002)
27. Lee AK, Sung SH, Kim YC, Kim SG. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-α, and COX-2 expression by sauchinone effects on I-κBα phosphorylation, C/EBP, and AP-1 activation. Brit. J. Pharmacol. 139: 11-20 (2003)
28. Hwang YH, Kim MS, Song IB, Lim JH, Park BK, Yun HI. Antiinflammatory effects of talosin A via inhibition of NF-kappaB activation in lipopolysaccharide-stimulated RAW264.7 cells. Biotechnol. Lett. 31: 789-795 (2009)
29. Park HG, Shim YY, Choi SO, Park WM. New method development for nanoparticle extraction of water-soluble beta-(1,3)-D-glucan from edible mushrooms, Sparassis crispa and Phellinus linteus. J. Agr. Food Chem. 57: 2147-2154 (2009)
30. Yu R, Lei W, Mandlekar S, Weber MJ, Der CJ, Wu J, Kong AN. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274: 27545-27552 (1999)
31. Jeong WS, Keum YS, Chen C, Jain MR, Shen G, Kim JH, Li W, Kong AN. Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. J. Biochem. Mol. Biol. 38: 167-176 (2005)
32. D'Agostino P, Ferlazzo V, Milano S, La Rosa M, Di Bella G, Caruso R, Barbera C, Grimaudo S, Tolomeo M, Feo S, Cillari E. Antiinflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line. Int. Immunopharmacol. 1: 1765-1776 (2001)
33. Lin JH, Yang SS. Mycelium and polysaccharide production of Agaricus blazei murrill by submerged fermentation. J. Microbiol. Immunol. 39: 98-108 (2006)
34. Pan MH, Ho CT. Chemopreventive effects of natural dietary compounds on cancer development. Chem. Soc. Rev. 37: 2558- 2574 (2008)
35. Hong JH, Youn KS, Choi YH. Characteristics of crude proteinbound polysaccharide from Agaricus blasei murill by extraction and precipitation conditions and its antitumor effect. Korean J. Food Sci. Technol. 36: 586-593 (2004)
36. Prawan A, Kundu JK, Surh YJ. Molecular basis of heme oxygenase-1 induction: Implications for chemoprevention and chemoprotection. Antioxid. Redox Sign. 7: 1688-1703 (2005)
37. Farombi EO, Surh YJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J. Biochem. Mol. Biol. 39: 479-491 (2006)
38. Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta 1470: M69-M78 (2000)
39. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol. Cancer Res. 4: 221-233 (2006)
40. Lim KM, Lee JY, Lee SM, Bae ON, Noh JY, Kim EJ, Chung SM, Chung JH. Potent anti-inflammatory effects of two quinolinedione compounds, OQ1 and OQ21, mediated by dual inhibition of inducible NO synthase and cyclooxygenase-2. Brit. J. Pharmacol. 156: 328-337 (2009)
41. Jin JQ, Li CQ, He LC. Down-regulatory effect of usnic acid on nuclear factor-kappaB-dependent tumor necrosis factor-alpha and inducible nitric oxide synthase expression in lipopolysaccharidestimulated macrophages RAW 264.7. Phytother. Res. 22: 1605-1609 (2008)
42. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy 4: 281-286 (2005)
43. Ghezzi P, Cerami A. Tumor necrosis factor as a pharmacological target. Mol. Biotechnol. 31: 239-244 (2005)
44. Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN. Activation of Nrf2-antioxidant signaling attenuates NFκBinflammatory response and elicits apoptosis. Biochem. Pharmacol. 76: 1485-1489 (2008)
45. Yang JL, Jang JH, Radhakrishnan V, Kim YH, Song YS. β-Glucan suppresses LPS-stimulaged NO production through the downregulation of iNOS expression and NF-βB transactivation in RAW 264.7 macrophages. Food Sci. Biotechnol. 17: 106-113 (2008)
46. Kim SY, Song HJ, Lee YY, Cho K-H, Roh YK. Biomedical issues of dietary fiber β-glucan. J. Korean Med. Sci. 21: 781-789 (2006)